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1. INTRODUCTION {#mbo31017-sec-0001}
===============

*Staphylococcus aureus* is one of the most adaptable human pathogens and is able to infect many organs and damage tissues, causing severe infections. One of the most interesting strategies is associated with its persistence, through changes from the aggressive wild‐type phenotype to small colony variant (SCV) forms, more adaptive long‐term persistent cells. In these dynamic changes, it becomes refractory to prolonged antimicrobial treatment required for chronic infections, recurrent osteomyelitis (OM), and prosthetic joint infections (PJIs); Tuchscherr & Löffler, [2016](#mbo31017-bib-0023){ref-type="ref"}). In particular, PJIs can have a dramatic impact on the quality of life of a patient, often requiring surgical intervention and prosthesis removal (Moore et al., [2017](#mbo31017-bib-0016){ref-type="ref"}; Purrello et al., [2016](#mbo31017-bib-0018){ref-type="ref"}; Stefani et al., [2012](#mbo31017-bib-0020){ref-type="ref"}).

Even if the prevalence of methicillin‐resistant *S. aureus* (MRSA) in these infections is lower than that of MSSA, these human pathogens are still problematic because they are often associated with antimicrobial resistance, leading to high rates of hospitalization and mortality as well as the burden of associated costs (Gould et al., [2011](#mbo31017-bib-0007){ref-type="ref"}).

In the assessment of the interaction between *S. aureus* isolates and osteoblasts during PJIs and OM, three events are crucial: adhesion, invasion, and the postinvasion process or internalization. Adhesion of *S. aureus* to host structures is a prerequisite for colonization and disease development and relies on the expression of a large number of cell surface proteins (adhesins) of the microbial surface component recognizing adhesive matrix molecules (MSCRAMM) and of the secretable expanded repertoire adhesive molecules (SERAM) classes. *S. aureus* osteoblast invasion plays a crucial role in the initiation and maintenance of inflammatory immune responses (Sinha & Fraunholz, [2010](#mbo31017-bib-0019){ref-type="ref"}). Recent studies have demonstrated that *S. aureus* is able to internalize in the osteoblast cytoplasm, and this localization can represent a reservoir of bacteria for chronic disease (Horn, Stelzner, Rudel, & Fraunholz, [2018](#mbo31017-bib-0010){ref-type="ref"}).

During postinvasion events, *S. aureus* is internalized in osteoblasts via a process that involves actin microfilaments, microtubules, receptor‐mediated endocytosis, and activation of signal transduction cascades. Osteoblasts release viable staphylococci, which are then able to reinfect and internalize in new osteoblasts, representing the potential key for prolonged and persistent infections (Garzoni & Kelley, [2009](#mbo31017-bib-0006){ref-type="ref"}; Josse, Velard, & Gangloff, [2015](#mbo31017-bib-0014){ref-type="ref"}). Many papers have reported *S. aureus* internalization in osteoblasts considering diverse aspects related to the mechanism of pathogenicity (Jevon et al., [1999](#mbo31017-bib-0012){ref-type="ref"}), the induction of various responses from the osteoblasts (Josse et al., [2016](#mbo31017-bib-0013){ref-type="ref"}), and their impact on the interaction between osteoclasts and osteoblasts (Josse et al., [2015](#mbo31017-bib-0014){ref-type="ref"}).

Furthermore, different cell culture models have been used to study the frequency of internalization of *Staphylococcus* spp. in osteoblasts. These assays involve the use of gentamicin or lysostaphin to eliminate the external and adherent bacterial cells, and the quantification of live bacteria is performed by host cell lysis and plate counting (Jevon et al., [1999](#mbo31017-bib-0012){ref-type="ref"}; Valour et al., [2013](#mbo31017-bib-0025){ref-type="ref"}; Wright & Friedland, [2004](#mbo31017-bib-0026){ref-type="ref"}). As reported in many papers, this method is time‐consuming and lacks reproducibility (Trouillet et al., [2011](#mbo31017-bib-0022){ref-type="ref"}).

Taking into consideration the disadvantages of the cell culture gold standard assay and the heterogeneity of the main Italian *S. aureus* invasive isolates recently described in 2015 (Campanile et al., [2015](#mbo31017-bib-0003){ref-type="ref"}), we aimed to (a) provide a novel method of detection of intracellular *S. aureus* by analyzing live host cells through imaging flow cytometry (IFC) to strengthen the conventional cell culture method and (b) confirm the reliability and reproducibility of this method validating the different proclivities to persist during cell infection (at 24 hr p.i.) of the main HA‐MRSA invasive isolates responsible for bone infections and PJIs, belonging to different epidemic clones.

2. MATERIAL AND METHODS {#mbo31017-sec-0002}
=======================

2.1. Strains included in the study {#mbo31017-sec-0003}
----------------------------------

The study sample consisted of 15 invasive MRSA isolates already molecularly characterized by standard genotyping methods internationally recognized as defining MRSA clones, and belonging to ST239‐SCC*mec*III, ST5‐SCC*mec*II, ST8‐SCC*mec*IV, ST228‐SCC*mec*I, and ST22‐SCC*mec*IVh, three strains for each clone. These strains were selected from a large collection of 640 MRSA strains isolated during an Italian national survey that was carried out in 2012. All the strains were phenotypically and molecularly characterized (Table [A1](#mbo31017-tbl-0001){ref-type="table"}) as previously reported (Bongiorno, Mongelli, Stefani, & Campanile, [2018](#mbo31017-bib-0002){ref-type="ref"}; Campanile et al., [2015](#mbo31017-bib-0003){ref-type="ref"}). The invasive isolate ATCC12598 (Cowan ST30‐t076; ATCC^®^ Standards Development Organization, LGC Standards S.r.l.) was used as control strain for invasion and persistence assays and for the statistical analysis of the results obtained with the cell culture method and IFC (McPherson et al., [2008](#mbo31017-bib-0015){ref-type="ref"}).

2.2. Eukaryotic cell culture preparation {#mbo31017-sec-0004}
----------------------------------------

Infection experiments were performed on the human osteosarcoma cell line MG‐63 (ATCC^®^ CRL‐1427™; Standards Development Organization, LGC Standards S.r.l.). During the expansion period, the cells were grown in 75 cm^2^ flasks with modified Eagle\'s medium (MEM), HEPES, GlutaMAX™ Supplement (cat. No. 42360024, containing 1 g/L [d]{.smallcaps}‐glucose, GIBCO™; Thermo Fisher Scientific Monza, Italy), supplemented with 10% FBS (fetal bovine serum; cat. No. 16000044, GIBCO™; Thermo Fisher Scientific) and 100 U/ml of penicillin/streptomycin (cat. No. 15070063 GIBCO™; Thermo Fisher Scientific). The cell culture was incubated at 37°C in a humidified atmosphere with 5% CO~2~ and 95% air. The medium was changed twice per week. Twenty‐four hours before infection 3 × 10^5^ cells were multi‐well plated on MEM medium, supplemented with 10% FBS without penicillin/streptomycin and washed twice with 500 μl MEM per well, before the infection step. A single 24‐well plate was used for the cell culture method using osmotic lysis, while a single 6‐well plate was used for cytofluorimetric analysis. All experiments were performed in triplicate.

2.3. Evaluation of the frequency of internalization and intracellular persistence in the cell culture model using MG‐63 osmotic lysis {#mbo31017-sec-0005}
-------------------------------------------------------------------------------------------------------------------------------------

The internalization frequency was evaluated in a cell culture model of infection in MG‐63 osteoblasts at a multiplicity of infection (MOI) of 100:1, as previously reported (Campoccia et al., [2018](#mbo31017-bib-0004){ref-type="ref"}). Moreover, to assess the final MOI, we previously tested MG‐63 infection with ATCC12598 at 12, 50, 100, and 200 MOI, observing that with 12 and 50 MOI the ability to internalize in nonspecialized cells such as osteoblasts for *S. aureus* was very low, instead, with 200 MOI, MG‐63 cultured cells showed phenomena of cytotoxicity.

Bacterial isolates were grown in Brain Heart Infusion broth (BHI; cat. No. CM1135; Oxoid Limited, Thermo Fisher Scientific Inc) at 37°C overnight. The bacterial concentration was evaluated by optical density (OD) at 600 nm. Bacterial suspensions were prepared using MEM supplemented with 10% FBS. MG‐63 cultures were infected for 2 and 24 hr in antibiotic‐free conditions; extracellular bacterial lysis was carried out for 1 hr at 37°C with 100 mg/ml lysostaphin (cat. No. L7386‐15MG; Sigma‐Aldrich, Merck KGaA; Figure [A1](#mbo31017-fig-0005){ref-type="fig"}). In addition, before and after lysostaphin treatment, the infected cell cultures were washed with PBS, and the culture medium was changed before the 24‐hr incubation.

Estimation of intracellular bacteria was determined 3 hr p.i. to assess the bacterial internalization processes and 24 hr p.i. to assess persistence, by osmotic MG‐63 cell lysis, serial dilution plating of the lysate on blood agar plates, incubation at 37°C overnight and CFU/ml counting. The proportion of internalized bacteria/MG‐63 cells was calculated considering the MOI, the number of MG‐63 cells, and the number of CFUs counted after cell lysis.

2.4. Evaluation of the bacterial intracellular persistence frequency by imaging cytofluorimetric analysis {#mbo31017-sec-0006}
---------------------------------------------------------------------------------------------------------

Infected cells, prepared as previously described at an MOI of 100:1, were first washed with 1× phosphate‐buffered saline (PBS; cat. No. P5493; Sigma‐Aldrich, Merck), followed by an incubation step of 3--5 min at 37°C with 0.05% trypsin‐EDTA solution (cat. No. T4049; Sigma‐Aldrich, Merck), and the cellular suspension was reversibly permeabilized with saponin 0.1% (cat. No. 55,255; Sigma‐Aldrich, Merck) in PBS. Saponin interacts with membrane cholesterol, selectively removing it and leaving holes in the membrane. This transient permeabilization does not require cell fixing. After 15 min in saponin, the bacterial cells were labeled with 0.08 μg/ml BODIPY™ FL vancomycin (VBFL; cat. No. V34850; Invitrogen™), the membrane‐impermeable green‐fluorochrome vancomycin analogue that specifically binds the cell‐wall peptidoglycan of Gram‐positive bacteria and does not penetrate intact cells. The suspensions were then washed three times with PBS to remove the transient permeabilization and checked under the microscope to be sure that the cells had maintained their cell integrity. The labeled cellular suspension was analyzed by a FlowSight^®^ Imaging Flow Cytometer (Amnis^®^ FlowSight^®^ Millipore, Merck), which quantitatively detects brightfield, darkfield, and fluorescent images with high sensitivity. This instrument acquires up to 12 images simultaneously of each cell or object including brightfield, scatter, and multiple fluorescent images at rates of up to 5,000 objects per second with high photonic sensitivity. Detailed analysis of intensity, location, and colocation of probes is achieved by IDEAS^®^ (Image Data Exploration and Analysis Software), which offers powerful tools for statistically robust analysis of images, as well as standard flow cytometry graphing tools and statistics for hundreds of morphological features in addition to intensity. Acquisition analysis was driven by the powerful INSPIRE^®^ and IDEAS^®^ packages, using the main function of the INSPIRE^®^ program during the acquisition and the IDEAS^®^ Spot Counting analysis during results generation (Amnis, EMD Millipore).

The spots recovered in cytofluorometry imaging (total spots and full cells) were examined in a representative sample of 10,000 events, and we then theoretically normalized the result on a sample of plated cells (300,000 cells/well) and compared the total spots recovered with the whole theoretically internalized sample.

2.5. Statistical model {#mbo31017-sec-0007}
----------------------

Statistical analysis and the relative graphs were made using GraphPad Prism 5 (GraphPad Software Inc.). Statistical significance was assessed using Student\'s *t* test, both for cell culture methods and cytofluorimetric analyses. The significance threshold was set at *p*‐value ≤ .05 (significant), *p*‐value ≤ .01 (highly significant), and *p*‐value ≤ .001 (extremely significant). In the cell culture assays, the colonies and the spots were counted and the data were plotted and represented as the mean ± standard deviation (*SD*) of the percentage of recovered internalized bacteria with respect to inoculated bacteria versus ATCC12598, obtained in at least two independent experiments performed in triplicate. In the flow cytometric assays, the number of single‐cell events analyzed was never less than 9,980 cells out of 10,000 events at the outset.

3. RESULTS {#mbo31017-sec-0008}
==========

3.1. Evaluation of the invasion of different MRSA genetic backgrounds in MG‐63 human osteoblasts in the cell culture model {#mbo31017-sec-0009}
--------------------------------------------------------------------------------------------------------------------------

The invasiveness of different MRSA genetic backgrounds was evaluated by the cell culture infection model, using 15 invasive HA‐MRSA strains belonging to the five different epidemic clones included in the study (ST239‐SCC*mec*III, ST5‐SCC*mec*II, ST8‐SCC*mec*IV, ST228‐SCC*mec*I, and ST22‐SCC*mec*IVh, 3 strains for each clone) at 3 hr postinfection (p.i.). The rates of infection (CFU/infected MG‐63) and ±*SD* recovered at 3 hr were **ATCC12598‐ST30** 3.2 × 10^6^ ± 3.7 × 10^5^; **ST239‐SCC*mec*III** 2.7 × 10^6^ ± 2.8 × 10^4^; **ST5‐SCC*mec*II** 3.3 × 10^6^ ± 5.8 × 10^5^; **ST8‐SCC*mec*IV** 2.4 × 10^6^ ± 1.4 × 10^5^; **ST228‐SCC*mec*I** 2.8 × 10^6^ ± 6.3 × 10^5^; and **ST22‐SCC*mec*IVh** 4.3 × 10^6^ ± 6.8 × 10^5^.

Three hours after the infection process, no substantial differences in the number of intracellular bacteria were observed, indicating that all analyzed strains had an internalization rate similar to one of the invasive strain ATCC12598 (Figure [A2](#mbo31017-fig-0007){ref-type="fig"} and Table [A2](#mbo31017-tbl-0002){ref-type="table"}).

3.2. Evaluation of the bacterial intracellular persistence frequency by imaging flow cytometric analysis---IFC {#mbo31017-sec-0010}
--------------------------------------------------------------------------------------------------------------

### 3.2.1. Construction of the analysis template on ATCC12598 {#mbo31017-sec-0011}

The frequencies of intracellular bacterial cells within MG‐63 osteoblasts were evaluated after selective VBFL‐bacterial labeling by the novel imaging flow cytometric approach using the new generation Amnis^®^ FlowSight^®^ Imaging Flow Cytometer.

We acquired 10,000 events for each sample and as quality control, the stained and not stained bacterial suspension to exclude autofluorescence; a negative control of infected, but not permeabilized cells, was also acquired to guarantee the exclusively intracellular localization of green spots. For each experiment, a sample of unmarked cells was acquired to exclude cellular autofluorescence or false‐negative results.

The acquisition analysis was driven by INSPIRE^®^ and IDEAS^®^ packages. The size of every single event was established during the acquisition phase employing the scatter plot set utilizing the diameter as a parameter. This portion was referred to as a single‐cell event. This first filter step was necessary to eliminate debris and cell aggregates. The 488 nm and 642 nm lasers were set to an intensity power of 30 mW for all experiments. Extracellular bacteria were efficiently disrupted by lysostaphin treatment, confirmed by the absence of fluorescence outside the MG‐63 cells, in all the experiments conducted for all the samples included in the study (Figure [1](#mbo31017-fig-0001){ref-type="fig"}).

![Images obtained by FlowSight^®^ Imaging Flow Cytometer (Amnis^®^ FlowSight^®^ Millipore, Merck KgaA, Darmstadt, Germany), acquiring 10,000 events per sample: (a) MG‐63, without spots inside the cell; (b) a single MG‐63 cell with four spots inside (each spot was considered as a single bacterial cell); and (c) a single MG‐63 cell with \>5 spots. CH1 brightfield; CH2 band nM 505--560; CH6 Side Scatter (SSC) 785 nM; CH1/CH2 merge brightfield and 505--560 nM band](MBO3-9-e1017-g001){#mbo31017-fig-0001}

Using IDEAS, population statistics and imaging were completely integrated; all results obtained were subdivided into two consequential steps: (a) The first analysis was performed on scatter plots using the Size Scatter in order to separate cells by size and fluorescence intensity, obtaining two large groups: labeled and unlabeled cells. On these two groups, the percentage of internalized bacteria were calculated; and (b) the second analysis was performed on a labeled cell subgroup, using the "spot counting" tool, that sets the fluorescence channel and acquires at least 20 individual events within the high and low spot categories. Evaluation of internalized bacteria by spot counting, according to the subcategories, the software identifies "N" subgroups divided by an increasing number of spots, and each subgroup was analyzed for mean fluorescence intensity (Figure [2](#mbo31017-fig-0002){ref-type="fig"}).

![The layout used for the analysis of internalized *S. aureus* during acquisition using IFC. The layout was created for the analysis of ATCC12598 after 24 hr postinternalization in MG‐63 and then applied to every single analysis for all internalization events: (a) Elimination of all events that had a noncircular shape (surface tension is responsible for the shape of liquid droplets. Although easily deformed, droplets of water tend to be pulled into a spherical shape by the cohesive forces of the surface layer. The spherical shape minimizes the necessary "wall tension" of the surface layer according to La Place\'s law. The cortical tension pulls the cell into a spherical shape, similar to surface tension pulling a water drop into a sphere), identifiable by the ratio between the area and the diameter, the ideal ratio of a spherical cell between width and length is 1, the graph identifies most of the events considered as "single cells" around this value. This step allowed us to acquire 10,000 events representing individual cells, eliminating debris and aggregates that would have distorted the subsequent analysis; (b) Comparison of the fluorescence intensity of the channel (in this example Ch02) corresponding to the labeled cells versus size scatter signal (Ch06). In this step, we have the creation of a cellular cloud characterized by size‐shape and fluorescence quantity that divided the total amount of cells into two large groups that only differ in the amount of fluorescence. This raw analysis step precedes the more precise spot counting step; (c) Final analysis using IDEAS software that was able (after setting parameters such as Spot Low cells and High Spot cells) to identify empty and full cells (shown in the first graph), and divide the event categories by the number of "fluorescent spots." For each identified category, it was possible to evaluate the amount of fluorescence and the average fluorescence. The software organized every single gallery (deriving from a category of "number of spots" of the spot counting) based on various parameters. Each gallery was evaluated for minima and maxima fluorescence intensity, evaluating the relative accuracy of the number of spots corresponding to the category assigned by the Spot Counting](MBO3-9-e1017-g002){#mbo31017-fig-0002}

### 3.2.2. Analysis of the sample {#mbo31017-sec-0012}

Figure [3a](#mbo31017-fig-0003){ref-type="fig"} shows the percentage of full versus empty MG‐63 cells, with respect to the control strain. ATCC12598 persisted inside 51% of MG‐63 at 24 hr p.i., and the same ability to persist was found in clones ST239 (47.82%) and ST22 (50.55%). The other clones analyzed were less able to persist inside MG‐63, and in particular, ST5 26.59% (*p* = .038), ST228 20.25% (*p* = .0120), and ST8 19.52% (*p* = .0054; Table [A3](#mbo31017-tbl-0003){ref-type="table"}). Detailed data for every single strain included in the sample are reported in Figure [A3](#mbo31017-fig-0008){ref-type="fig"} and Table [A4](#mbo31017-tbl-0004){ref-type="table"}.

![(a) Evaluation of the internalization frequency by IFC. After 24 hr p.i. at an MOI of 100:1, external and adherent bacteria were removed by lysostaphin treatment. The MG‐63 cells infected with the different strains were stained with the membrane‐impermeable fluorochrome VBFL and analyzed on a flow cytometer (Amnis FlowSight Millipore), acquiring 10,000 events per sample. The graph reports the percentage of spots for cell ± *SD* for each strain for three different experiments. Statistical significative *p*‐value ≤ .05 \*; highly significative ≤.01\*\*; extremely significative ≤.001\*\*\*. (b) Invasion rate of MRSA strains from different genetic backgrounds. After 2 hr of infection at an MOI of 100:1, external and adherent bacteria were removed by lysostaphin treatment for 1 hr. The infected MG‐63 cells were lysed at 24 hr postinfection after a lysostaphin treatment for 1 hr. The MG‐63 cells infected with the different strains were osmotically lysed, and the number of intracellular bacteria was determined by plating serial dilutions of the lysates on blood agar plates and counting the colonies grown after overnight incubation. The graph reports the mean ± *SD* for each clone for three different experiments](MBO3-9-e1017-g003){#mbo31017-fig-0003}

These results of the internalization described above derive from Figure [3b](#mbo31017-fig-0003){ref-type="fig"} in which we defined clones with 0 spots, 1 to 5, and over 6 spots. For the first category, 0 spots inside MG‐63 cells (empty cells), the sample can be divided into two major groups, the first group included strains belonging to ST5, ST228, and ST8 and showed a percentage of empty cells ranging from 78.8% to 80% (in particular, ST5: 78.80 ± 2.46%; ST8: 79.80 ± 2.46; ST228: 80 ± 7.65%); and the second group included strains belonging to ST239, ST22, and ATCC12598 and showed about 51.5% of empty cells (in particular, ST239: 52.17 ± 7.65; ST22: 51.11 ± 5.76; ATCC12598: 51.92 ± 1.15). For the second category, 1 to 5 spots inside MG‐63 cells, we found the same two groups, the first one (ST5, ST228, and ST8) showed a percentage of about 19.5% cells (in particular, ST5: 19.87 ± 2.05%; ST8: 19.49 ± 3.76; ST228: 19.35 ± 7.42%) and the second one showed a percentage ranging from 41.9% to 45% (in particular, ST239: 42.33 ± 3.4; ST22: 45.12 ± 4.16; ATCC12598: 41.97 ± 0.36). The third category, MG‐63 with more than six spots inside, were less represented: 0.64 ± 0.33% for ST228, 0.71 ± 3.76% for ST8, and 1.33 ± 2.05% for ST5. Moreover, in this case, ST22 (3.77 ± 1.6%) and ST239 (5.8 ± 2.2%) showed values similar to ATCC12598 (6.11 ± 0.78%).

3.3. Evaluation of the intracellular persistence of different MRSA genetic backgrounds in MG‐63 human osteoblasts in the cell culture model {#mbo31017-sec-0013}
-------------------------------------------------------------------------------------------------------------------------------------------

After assessing the internalization process, the proclivity to persist inside MG‐63 was examined at 24 hr p.i., as reported in Figure [4a](#mbo31017-fig-0004){ref-type="fig"}.

![Evaluation of the persistence frequency by IFC evaluation, after 24 hr p.i. at an MOI of 100:1, external and adherent bacteria were removed by lysostaphin treatment. The MG‐63 cells infected with the different strains were stained with the membrane‐impermeable fluorochrome VBFL and analyzed on a flow cytometer (Amnis FlowSight Millipore), acquiring 10,000 events per sample. (a) The graph shows the distribution of spots corresponding to the category assigned by the Spot Counting, for each clone. (b) The graph shows the percentage of full versus empty cells, recovered from spot counting. The graph reports the percentage of spots for cell ± *SD* for each strain for three different experiments. Statistical significative *p*‐value ≤ .05\*; highly significative ≤ .01\*\*; extremely significative ≤ .001\*\*\*](MBO3-9-e1017-g004){#mbo31017-fig-0004}

Although not statistically significant, the levels of intracellular bacteria changed at 24h after the infection process; in particular, ST239 (*p* = .99), ST8 (*p* = 1), and ST22 (*p* = .5585) showed a greater ability to persist within MG‐63 osteoblasts, with respect to ST5 (*p* = .169) and ST228 (*p* = .4881) versus the ATCC12598 invasive control strain (Table [A5](#mbo31017-tbl-0005){ref-type="table"}).

3.4. Cell culture methods versus imaging flow cytometric analysis {#mbo31017-sec-0014}
-----------------------------------------------------------------

The rate of persistence at 24 hr was evaluated comparing the data obtained with the conventional cell culture method and data obtained with IFC and was carried out considering the number of intracellular spots per bacteria cell, as shown in Figure [4b](#mbo31017-fig-0004){ref-type="fig"}, for each MRSA genetic background. Statistical analysis was conducted versus ATCC12598, and the percentage of internalization ± *SD*, *p*‐values, and 95% confidence intervals are reported in Table [A6](#mbo31017-tbl-0006){ref-type="table"}.

Comparing the data set obtained with the two techniques, the rate of persistence of clones of ST239 and ST22 in MG‐63 cells was similar to that of ATCC12598; clones ST5 and ST228 were less able to persist. The only exception was clone ST8 that showed a result comparable to ATCC12598 by the cell culture method; however, this result was not confirmed by IFC.

The overall trend in all clones of the two techniques was the same; moreover, the IFC method was more sensitive as demonstrated by the *SD* values that were lower with respect to the conventional culture method.

4. DISCUSSION AND CONCLUSIONS {#mbo31017-sec-0015}
=============================

*Staphylococcus aureus* is considered an extracellular pathogen; moreover, strains belonging to different genetic backgrounds have been known to develop an aptitude to invade and survive in phagocytic and nonphagocytic cells, and this ability can play a significant role in related diseases. Host cell invasion contributes to protecting *S. aureus* from antibiotics and the immune response and establishes a latent reservoir of bacteria that can be responsible, in particular in osteomyelitis, for the pathogenesis of this chronic and recurrent infection (Tuchscherr et al., [2011](#mbo31017-bib-0024){ref-type="ref"}).

*Staphylococcus aureus*/host cell interaction is strongly conditioned by both host cell type and *S. aureus* isolate; in fact, the ability to internalize and survive in osteoblasts exhibits strain‐dependent differences (Strobel et al., [2016](#mbo31017-bib-0021){ref-type="ref"}).

In our study, different clinical MRSA strains, from invasive infections and belonging to the main worldwide HA‐MRSA genetic backgrounds, were compared for their persistence ability. Our results highlighted the heterogeneity of the different clones to persist during cell infection.

The results obtained by the cell culture method demonstrated that initially (3 hr p.i.) all clones were internalized in MG‐63 human osteoblasts, supporting the fact that a variety of genetic backgrounds are capable of invading host cells, but were able to differentially resist over 24 hr p.i. as demonstrated by the variable slight increase or decrease in CFU recovery; these results also suggest that osteoblasts could represent intracellular persistence niches in which *S. aureus* strains persist intracellularly and possibly replicate for a longer infection time. Our observation was supported by a previous study in which the ability of *S. aureus* to survive intracellularly for up to 7 days in osteoblasts was demonstrated (Hamza & Li, [2014](#mbo31017-bib-0008){ref-type="ref"}).

Using the cell culture assay, we found a wide standard deviation among the different experiments for the same isolates, resulting from a large number of factors that can influence this experiment. Moreover, comparing the internalization rate of the different clones with the standard strain, no statistical significance in the ability to internalize and survive within osteoblasts was found.

The data from routine cell culture assays were improved with those obtained by the more sensitive and reliable IFC method that, together with specialized analytic software, combines the statistical power and fluorescence sensitivity of standard flow cytometry with the spatial resolution and quantitative morphology of digital microscopy, to accurately address cell counting and internalization scoring in intracellular infections (Haridas, Ranjbar, Vorobjev, Goldfeld, & Barteneva, [2017](#mbo31017-bib-0009){ref-type="ref"}).

Fully integrated IFC and statistical analyses, with the same conditions of internalization (24 hr), allowed us to better standardize the experiments: This method was more sensitive, allowing the acquisition of a very high number of events, and was reproducible for every single sample. Our results indicated that, despite the bacterial invasion rates reflected in the trend of the cell culture data, IFC assays detected important differences that would otherwise have been undetectable.

All isolates belonging to ST5‐II, ST8‐IV, and ST228‐I showed a statistically significant lower aptitude to intracellularly subsist (demonstrated by both the total number of spots and the number of infected cells). All ST239‐III and ST22‐IVh isolates had intracellular frequencies equal to or greater than those of the reference ATCC12598 strain, suggesting their possible role as invasive and persistent clones responsible for chronic and recurrent infections.

Statistically relevant results obtained by imaging flow cytometry assays allowed us to understand that the intracellular rates did not depend on the number of bacterial cells that manage to enter/replicate inside a single MG‐63 osteoblast, but on the total number of cells that were infected. The ability to internalize and persist inside osteoblasts seems, therefore, not only related to the clone but to other factors that deserve to be investigated.

Furthermore, our observations have been supported by the increase, in the last ten years, of strains belonging to ST239 and ST22 associated with bacteremia and PJIs (Coombs, Daley, Lee, Pang, [2019](#mbo31017-bib-0005){ref-type="ref"}; Jain, Chowdhury, Datta, Chowdhury, & Mukhopadhyay, [2019](#mbo31017-bib-0011){ref-type="ref"}; Peng et al., [2019](#mbo31017-bib-0017){ref-type="ref"}) and probably associated with prophage‐mediated virulence determinants (*sas*X), crucial for colonization, immune evasion, and host cell invasion (Bakthavatchalam, Triplicane Dwarakanathan, Munusamy, Jennifer, & Veeraraghavan, [2019](#mbo31017-bib-0001){ref-type="ref"}).

This study presents some limitations that should be mentioned: whole‐genome sequencing analysis, for detecting different genetic variants and gene‐expression studies, and for determining whether a particular gene or set of genes is responsible for the specific internalization behavior, was not performed. The pathogenic and molecular characteristics that enhance the aptitude to internalize in, escape from, or persist within host cells undoubtedly reside in the differential expression of regulatory and virulence genes (Horn et al., [2018](#mbo31017-bib-0010){ref-type="ref"}; Josse et al., [2015](#mbo31017-bib-0014){ref-type="ref"}).

The current study contributes to our understanding of the differential interaction between osteoblasts and invasive MRSA strains belonging to different genetic backgrounds. By means of an imaging flow cytometry‐based approach, we demonstrated that internalization is a pathophysiological pathway of some MRSA depending on the total number of cells infected and not on the bacterial cells that enter each osteoblast. Furthermore, even if our strains were not homogeneous in terms of genetic backgrounds and virulence factors, ST22‐IVh and ST239‐III showed higher intracellular persistence in host cells, making them more prone to developing chronic and recurrent infections. We believe that our study provides additional information useful to predict the proclivity of some staphylococcal clones associated with recurrent and chronic infections, to invade, internalize, and persist within human cells, with respect to others.
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![Image obtained with Leica DMI 4,000 20× (a, b and c). (a) MG‐63 after 1h of infection with 7SA‐ST8‐SCC*mec*IV, bacterial cells were present all around the MG‐63 cells (red arrow) and in the cell culture space between MG‐63 cells (blue arrow); (b) after 2 hr of infection and 1 hr of lysostaphin treatment, there were no bacteria in cell culture spaces between MG‐63 cells, and (c) the MG‐63 cell culture after 24 hr of infection](MBO3-9-e1017-g005){#mbo31017-fig-0005}

![Invasion rate of MRSA strains from different genetic backgrounds. After 2 hr of infection at an MOI of 100:1, external and adherent bacteria were removed by lysostaphin treatment for 1 hr. The MG‐63 cells infected with the different strains were osmotically lysed, and the number of intracellular bacteria was determined by plating serial dilutions of the lysates on blood agar plates and counting the colonies grown after overnight incubation at 37°C. The graph reports the mean ± *SD* for each clone for two different experiments](MBO3-9-e1017-g006){#mbo31017-fig-0007}

![Evaluation of the internalization frequency by IFC. At 24 hr p.i. at an MOI of 100:1, external and adherent bacteria were removed by lysostaphin treatment. The MG‐63 cells infected with the different strains were stained with the membrane‐impermeable fluorochrome VBFL and analyzed on a flow cytometer (Amnis FlowSight Millipore), acquiring 10,000 events per sample. The graph reports the average amount of spots per cell ± *SD* for each strain for three different experiments](MBO3-9-e1017-g007){#mbo31017-fig-0008}
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###### 

The table reports the phenotypical and molecular characteristics of the sample included in the study

  LAB CODE   ST‐SCC*mec*‐Spa type   Source        FOX   CN   DA   E   CIP   TE   SXT   K   RD      BPR   DAL     CPT   LNZ   DPT   TGC     FU      VA    TC     GRD
  ---------- ---------------------- ------------- ----- ---- ---- --- ----- ---- ----- --- ------- ----- ------- ----- ----- ----- ------- ------- ----- ------ -------
  1SA        239‐III‐ t030          Wound         R     R    R    R   S     R    S     R   \>32    2     0.125   2     2     1     0.25    \>256   0.5   0.25   VSSA
  2SA        241‐III‐t037           Wound         R     R    Ri   R   R     R    R     R   2       2     0.125   2     2     0.5   0.25    \>256   1     2      VSSA
  3SA        239‐III‐t037           Blood         R     R    Ri   R   R     R    R     R   2       1     0.25    2     2     1     0.25    \>256   1     0.5    VSSA
  4SA        5‐II‐t002              Blood         R     R    Ri   R   R     R    S     S   16      4     0.125   4     4     0.5   0.5     4       1     2      VSSA
  5SA        5‐II‐t2154             Blood         R     R    S    R   R     R    S     R   \>32    2     0.012   4     32    0.5   0.5     \>256   1     0.5    hVISA
  6SA        5‐II‐t002              CVC           R     S    R    R   R     S    S     R   0.008   4     0.125   2     1     1     0.125   0.064   1     0.5    hVISA
  7SA        8‐IV‐t008              Hip fistula   R     R    R    R   R     R    S     R   \>32    2     0.125   2     4     1     0.125   0.064   2     2      hVISA
  8SA        8‐IVc‐t008             Bronchial     R     S    S    S   R     S    S     S   0.008   2     0.125   2     0.5   0.5   0.125   0.125   1     1      VSSA
  9SA        8‐IVc‐t008             Bronchial     R     R    S    R   R     S    S     R   0.016   1     0.064   1     0.5   0.5   0.125   0.125   2     0.5    hVISA
  10SA       228‐I‐t041             Blood         R     R    R    R   R     S    S     R   \>32    2     0.125   1     8     1     0.125   0.125   1     1      VSSA
  11SA       228‐I‐t041             Knee biopsy   R     R    R    R   R     I    S     R   2       2     0.064   4     2     0.5   0.125   0.064   2     1      hVISA
  12SA       228‐I‐t001             CVC           R     R    Ri   R   R     S    S     R   0.016   2     0.064   2     0.5   0.5   0.125   0.125   1     2      VSSA
  13SA       22‐IVh‐t032            Blood         R     R    S    S   R     R    S     R   \>32    0.5   0.125   1     0.5   0.5   0.06    0.125   1     0.25   VSSA
  14SA       22‐IVh‐t032            Blood         R     S    Ri   R   R     S    S     S   0.008   1     0.064   1     1     1     0.125   0.064   0.5   0.25   VSSA
  15SA       22‐IVh‐t902            Blood         R     S    Ri   R   S     R    S     S   \>32    1     0.125   0.5   2     2     0.064   0.125   1     0.25   VSSA

Abbreviations: FOX, cefoxitin; CN, gentamicin; DA, clindamycin; E, erythromycin; CIP, ciprofloxacin; TE, tetracycline; SXT, trimethoprim/sulfamethoxazole; K, kanamycin; RD, rifampin; BPR, ceftobiprole; DAL, dalbavancin; CPT, ceftaroline; LNZ, linezolid; DPT, daptomycin; TGC, tigecycline; FU, fusidic acid; VA, vancomycin; TC, teicoplanin; GRD, MIC test strip glycopeptide resistance detection; Ri, Inducible clindamycin resistance; clone characterization by means of: ST, Sequence Type; SCC*mec*, Staphylococcal Cassette Chromosome *mec*; *spa* type, staphylococcal protein A.
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###### 

The statistical analysis relative to strain invasiveness was performed by comparing the rate of infection of each strain with the rate of infection of ATCC12598 as control for cell culture method at 3 hr p.i., using *t* test, *p* value and 95% of confidence

  *t* Test                               ATCC12598‐ST30              ST239‐SCCmecIII                   ST5‐SCCmecII                      ST8‐SCCmecIV                     ST228‐SCCmecI                     ST22‐SCCmecIVh
  -------------------------------------- --------------------------- --------------------------------- --------------------------------- -------------------------------- --------------------------------- --------------------------------
  Rate of Infection CFU/infected MG‐63   3.2 × 10^6^ ± 3.7 × 10^5^   2.7 × 10^6^ ± 2.8 × 10^4^         3.3 × 10^6^ ± 5.8 × 10^5^         2.4 × 10^6^ ± 1.4 × 10^5^        2.8 × 10^6^ ± 6.3 × 10^5^         4.3 × 10^6^ ± 6.8 × 10^5^
  *p* value                              ---                         .2548                             .9819                             .0932                            .6016                             .2394
  95% confidence interval                ---                         −1.545 × 10^6^ to 5.455 × 10^5^   −1.904 × 10^6^ to 1.937 × 10^6^   −2.001 × 10^6^ to 2.34 × 10^5^   −2.461 × 10^6^ to 1.627 × 10^6^   −1.095 × 10^6^ to 3.26 × 10^6^
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###### 

The statistical analysis relative to strain invasiveness was performed by comparing the rate of infection of each strain with the rate of infection of ATCC12598 as control for cell culture method at 3 hr p.i., using *t* test, *p* value and 95% of confidence

  *t*Test                                                                            ACTT12598‐ST30   ST239‐SCCmecIII   ST5‐SCCmecII      ST8‐SCCmecIV      ST228‐SCCmecI    ST22‐SCCmecIVh
  ---------------------------------------------------------------------------------- ---------------- ----------------- ----------------- ----------------- ---------------- -----------------
  \% of internalization ± *SD*                                                       51.18 ± 1.19     47.82 ± 1.68      26.59 ± 2.05      12.52 ± 3.185     20.25 ± 4.24     50.55 ± 3.71
  *p*‐Value of internalized bacteria recovered from spot counting versus ATCC12598   --               .2876             **.038\***        **.0054\*\*\***   **.0120\*\***    .9077
  95% confidence interval                                                            --               4.921 to −11.63   15.01 to −34.16   17.82 to 4.551    12.93 to 48.93   15.28 to −16.54

The table reports the detailed statistical data obtained using *t* test versus ATCC12598: % of internalization, *p‐*value and 95% confidence. Statistically significant *p*‐value ≤.05\*; highly significant ≤.01\*\*; extremely significant ≤.001\*\*\*.

The bold values are statistically significant.

John Wiley & Sons, Ltd

###### 

The statistical analysis relative to strain invasiveness was performed by comparing the rate of infection of each strain with the rate of infection of ATCC12598 as control for cell culture method at 3 hr p.i., using *t* test, *p* value and 95% of confidence

  *t* Test                             ATCC12598‐ST30   1SA‐ST239          2SA‐ST239         3SA‐ST239           4SA‐ST5            5SA‐ST5            6SA‐ST5            7SA‐ST8           8SA‐ST8            9SA‐ST8             10SA‐ST228         11SA‐ST228         12SA‐ST228         13SA‐ST22         14SA‐ST22          15SA‐ST22
  ------------------------------------ ---------------- ------------------ ----------------- ------------------- ------------------ ------------------ ------------------ ----------------- ------------------ ------------------- ------------------ ------------------ ------------------ ----------------- ------------------ -----------------
  \% of internalization ± *SD*         50.49 ± 0.69     45.20 ± 3.58       50.33 ± 1.19      47.98 ± 0.63        29.82 ± 1.2        27.59 ± 2.5        22.49 ± 1.58       20.78 ± 1.659     13.68 ± 1.34       20.43 ± 0.72        20.74 ± 1.04       12.89 ± 0.59       27.59 ± 1.12       56.24 ± 2.34      45.37 ± 1.31       50.70 ± 1.27
  *p*‐Value N cells versus ATCC12598   ---              .3380              .9261             .0791               **.0012\*\***      **.006\*\***       **.0008\*\***      **.0009\*\***     **.0002\*\***      **\<.0001\*\*\***   **.0002**          **\<.0001**        **.0009**          .1573             .0633              .8725
  95% confidence interval              ---              −20.09 to −9.513   −5.320 to 4.994   −5.568 to −0.5416   −26.12 to −15.22   −33.34 to −12.46   −34.49 to −21.50   −36.72 to 22.70   −41.74 to −31.87   −33.44 to 29.69     −34.33 to −25.18   −40.54 to −32.56   −28.26 to −17.54   −4.005 to 15.51   −10.78 to 0.5308   −5.169 to 5.769

The table reports the detailed statistical data obtained using *t* test versus ATCC12598: % of internalization, *p‐*value and 95% of confidence. Statistically significant *p*‐value ≤.05\*; highly significant ≤.01\*\*, extremely significant ≤.001\*\*\*.

The bold values are statistically significant.
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###### 

The statistical analysis relative to strain invasiveness was performed by comparing the rate of infection of each strain with the rate of infection of ATCC12598 as control for cell culture method at 3 hr p.i., using *t* test, *p* value and 95% of confidence

  *t* Test                               ATCC12598‐ST30              ST239‐SCC*mec*III                 ST5‐SCC*mec*II                    ST8‐SCC*mec*IV                     ST228‐SCC*mec*I                    ST22‐SCC*mec*IVh
  -------------------------------------- --------------------------- --------------------------------- --------------------------------- ---------------------------------- ---------------------------------- --------------------------------
  Rate of Infection CFU/infected MG‐63   1.9 × 10^6^ ± 4.6 × 10^5^   2.5 × 10^6^ ± 1.8 × 10^5^         1.5 × 10^6^ ± 3.8 × 10^5^         2.5 × 10^6^ ± 4.3 × 10^5^          2.1 × 10^6^ ± 1.3 × 10^5^          3.6 × 10^6^ ± 1.7 × 10^6^
  *p* Value                              ---                         .99                               .169                              1.0                                .4881                              .5585
  95% confidence interval                ---                         −3.774 × 10^5^ to 3.741 × 10^6^   −6.592 × 10^5^ to 2.666 × 10^6^   −1.763 × 10 ^6^ to 1.763 × 10^6^   −9.670 × 10 ^5^ to 1.701 × 10^6^   −6.129 × 10^6^ to 3.84 × 10^6^

John Wiley & Sons, Ltd

###### 

The statistical analysis relative to strain invasiveness was performed by comparing the rate of infection of each strain with the rate of infection of ATCC12598 as control for cell culture method at 3 hr p.i., using *t* test, *p* value and 95% of confidence.

  *t* Test                       ATCC12598‐ST30              ST239‐SCC*mec*III               ST5‐SCC*mec*II                 ST8‐SCC*mec*IV                 ST228‐SCC*mec*I                ST22‐SCC*mec*IVh
  ------------------------------ --------------------------- ------------------------------- ------------------------------ ------------------------------ ------------------------------ -------------------------------
  Average spots/infected MG−63   3.9 × 10^5^ ± 2.1 × 10^4^   2.6 × 10^5^ ± 3.6 × 10^4^       1.3 × 10^5^ ± 2.5 × 10^4^      1.1 × 10^5^ ± 2.4 × 10^4^      1.08 × 10^5^ ± 2.6 × 10^4^     3.5 × 10^5^ ± 4.7 × 10^4^
  *p* Value                      ---                         .084                            **.002**                       **.004**                       **.0049**                      .5762
  95% confidence interval        ---                         −3.14 × 10^5^ to 2.84 × 10^4^   1.76 × 10^5^ to 3.37 × 10^4^   1.69 × 10^5^ to 3.91 × 10^4^   1.62 × 10^5^ to 4.01 × 10^4^   −1.61 × 10^5^ to 2.40 × 10^4^

Statistical data versus ATCC12598, using *t* test, *p* value and 95% of confidence. Statistically significant *p*‐value ≤.05\*; highly significant ≤.01\*\*, extremely significant ≤.001\*\*\*.

The bold values are statistically significant.
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